Liporase vs Hyalase Dessau & Ldase: A Professional Comparison

For clinics evaluating which hyaluronidase to stock, understanding the primary market options is the first step. The following table provides a high-level comparison of three commonly sourced products: Liporase, Hyalase Dessau, and Ldase.

This table summarizes the core attributes that influence purchasing decisions for aesthetic professionals, from supply chain origin to relative cost.

Liporase, manufactured by Daehan New Pharm in South Korea, is a widely sourced hyaluronidase in the international aesthetics market. It is supplied as a lyophilized (freeze-dried) powder in vials, each containing 1,500 International Units (I.U.) of hyaluronidase.

Professionals stock Liporase primarily for dissolving hyaluronic acid-based dermal fillers, either to correct overfilling, asymmetry, or to manage vascular complications. Its market position is defined by its cost-effectiveness relative to European counterparts, making it a frequent choice for high-volume clinics. The wholesale price structure often includes volume-based discounts, such as an illustrative single-unit price of $82.0 with tiers offering 4-8% reductions for bulk orders. You can find this and other essential clinic supplies in the Aesthetic accessory catalog.

Hyalase Dessau is a German-manufactured hyaluronidase from Riemser Pharma. It is often considered a benchmark product, particularly in European markets, due to its long history and established regulatory approvals in those regions. Like Liporase, it is typically available in 1500 I.U. vials of lyophilized powder.

The primary distinguishing factor for Hyalase is its market positioning as a premium, pharma-grade product, which is reflected in its higher wholesale price point. Clinics operating under stringent local regulations or those that prefer to source EU-manufactured products may select Hyalase Dessau. Its performance profile is well-documented, but the procurement cost is a significant consideration for inventory managers.

Ldase by Humedix is another hyaluronidase originating from South Korea, positioning it as a direct market alternative to Liporase. It shares a similar product profile: 1500 I.U. of lyophilized hyaluronidase powder per vial. Its intended use in aesthetics mirrors that of Liporase, focusing on the enzymatic degradation of hyaluronic acid.

For procurement managers, the choice between Liporase and Ldase often comes down to supplier relationships, availability, and marginal price differences. Both products represent the Korean approach to aesthetic supplies, balancing quality with competitive pricing. Sourcing decisions between the two may also be influenced by specific formulation details or practitioner preference based on past handling experience. For an overview of sourcing other specialized Korean products, see our Professional's Guide to Sourcing Hairna Exosome Hair Fill.

All three products are supplied as powders and require reconstitution with sterile normal saline (0.9% sodium chloride) before professional use. The practitioner determines the final concentration by adjusting the volume of saline added.

• Standard Reconstitution: A common protocol involves adding 1-3 mL of saline to a 1500 I.U. vial, though the exact dilution depends on the specific clinical application, such as the density of the filler being dissolved or the size of the target area.
• Stability: Once reconstituted, hyaluronidase has a limited shelf life and should be used promptly. Manufacturer guidelines typically recommend immediate use and refrigeration for any short-term storage, though this varies.
• Administration: The reconstituted solution is administered via injection. For certain protocols, practitioners may mix the solution with a local anesthetic to improve patient comfort during the procedure. Products like Huons Lidocaine HCI Inj. are frequently stocked for this purpose, subject to local regulations and treatment protocols.

The decision of which hyaluronidase to source depends on the clinic's business model, regulatory environment, and client base.

• For High-Volume or Cost-Conscious Clinics: Liporase and Ldase are strong candidates. Their competitive wholesale pricing allows for better margin control, especially for clinics that perform a high number of corrective procedures or use hyaluronidase as an adjunct to other treatments. Their South Korean origin is well-accepted in many international markets.

• For Clinics Prioritizing EU Regulatory Alignment: Hyalase Dessau is the logical choice. Its German manufacturing and established presence in the EU market can simplify compliance in certain jurisdictions. The premium price is factored in as a cost of adhering to specific supply chain requirements or marketing a preference for European pharmaceuticals.

A diversified inventory strategy, similar to how clinics might stock different filler brands or botulinum toxins, can also be effective. For further reading on sourcing strategies, explore our Professional's Sourcing Guide for Wholesale Botox Cosmetic.